基于磁共振成像的影像组学在垂体腺瘤中的应用现状及进展

doi:10.3760/cma.j.cn441417-20240926-05011

摘要/Abstract

摘要：

影像组学是一种从医学图像中［电子计算机断层扫描（CT）、磁共振成像（MRI）、正电子发射计算机断层显像（PET-CT）等］高通量挖掘定量特征工具，在垂体腺瘤（PA）研究中的应用价值较高。从垂体MRI图像中提取的影像组学特征可为PA诊疗提供信息，如预测术后肿瘤复发、肿瘤侵袭性、肿瘤质地、手术切除率、药物治疗反应、术后并发症、术前肿瘤亚型等。本文综述基于MRI的影像组学预测PA术后复发、侵袭性和质地的应用现状及进展。

关键词:

垂体腺瘤, 影像组学, 磁共振成像, 复发, 侵袭性, 质地, 进展

Abstract:

Radiomics is a tool for high-throughput mining of quantitative features from medical images such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission computed tomography (PET-CT). It has become increasingly valuable in the study of pituitary adenoma (PA). The radiomic features extracted from pituitary MRI can provide relevant information for PA diagnosis and treatment. For example, there are relevant reports on predicting postoperative tumor recurrence, tumor invasiveness, tumor texture, surgical resection rate, drug treatment response, postoperative complications, and preoperative tumor subtypes. This article mainly reviews the application status and progress of radiomics based on MRI images in predicting postoperative tumor recurrence, tumor invasiveness, and tumor texture in PA patients.

Key words:

Pituitary adenoma, Radiomics, Magnetic resonance imaging, Recurrence, Invasiveness, Texture, Progress

莫家婵范万峰姜兴岳.

基于磁共振成像的影像组学在垂体腺瘤中的应用现状及进展 [J]. 国际医药卫生导报, 2025, 31(5): 757-760.

Mo Jiachan, Fan Wanfeng, Jiang Xingyue.

Application status and progress of MRI based radiomics in pituitary adenoma [J]. International Medicine and Health Guidance News, 2025, 31(5): 757-760.

参考文献

[1] Tritos NA, Miller KK. Diagnosis and management of pituitary adenomas: a review[J]. JAMA, 2023, 329(16):1386-1398. DOI: 10.1001/jama.2023.5444.
[2] Chin SO. Epidemiology of functioning pituitary adenomas[J]. Endocrinol Metab (Seoul), 2020, 35(2):237-242. DOI: 10.3803/EnM.2020.35.2.237.
[3] Pernik MN, Montgomery EY, Isa S, et al. The natural history of non-functioning pituitary adenomas: a meta-analysis of conservatively managed tumors[J]. J Clin Neurosci, 2022, 95:134-141. DOI: 10.1016/j.jocn.2021. 12.003.
[4] Yavropoulou MP, Tsoli M, Barkas K, et al. The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs)[J]. Endocr Relat Cancer, 2020, 27(10):R375-R390. DOI: 10.1530/ERC-20- 0136.
[5] 曾白云,梁建峰,余敦星,等.神经导航结合内窥镜在巨大垂体腺瘤手术中的应用[J].国际医药卫生导报,2006,12(13):15-17.
[6] Almeida JP, Tabasinejad R, Kalyvas A, et al. The importance of long term follow up after endoscopic pituitary surgery: durability of results and tumor recurrence[J]. Neurol India, 2020, 68(Supplement):S92-S100. DOI: 10.4103/0028-3886.287675.
[7] Bioletto F, Prencipe N, Berton AM, et al. Radiomic analysis in pituitary tumors: current knowledge and future perspectives[J]. J Clin Med, 2024, 13(2):336. DOI: 10.3390/jcm13020336.
[8] Koong K, Preda V, Jian A, et al. Application of artificial intelligence and radiomics in pituitary neuroendocrine and sellar tumors: a quantitative and qualitative synthesis[J]. Neuroradiology, 2022, 64(4):647-668. DOI: 10.1007/s00234-021-02845-1.
[9] Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer, 2012, 48(4):441-446. DOI: 10.1016/j.ejca.2011.11.036.
[10] 吴雪婷,陈晓仪,吴怡雯,等.超声影像组学在乳腺癌中应用的研究进展[J].国际医药卫生导报,2022,28(4):484-487.DOI:10.3760/cma.j.issn.1007-1245.2022.04.010.
[11] 梁芳蓉,杨蕊梦.MRI影像组学在胶质瘤术前分级预测中的研究进展[J].广州医药,2024,55(3):221-230.DOI:10.3969/j.issn.1000-8535.2024.03.002.
[12] van Timmeren JE, Cester D, Tanadini-Lang S, et al. Radiomics in medical imaging-"how-to" guide and critical reflection[J]. Insights Imaging, 2020, 11(1):91. DOI: 10.1186/s13244-020-00887-2.
[13] Avery E, Sanelli PC, Aboian M, et al. Radiomics: a primer on processing workflow and analysis[J]. Semin Ultrasound CT MR, 2022, 43(2):142-146. DOI: 10.1053/j.sult.2022.02.003.
[14] Shur JD, Doran SJ, Kumar S, et al. Radiomics in oncology: a practical guide[J]. Radiographics, 2021, 41(6):1717-1732. DOI: 10.1148/rg.2021210037.
[15] Zhang Y, Ko CC, Chen JH, et al. Radiomics approach for prediction of recurrence in non-functioning pituitary macroadenomas[J]. Front Oncol, 2020, 10:590083. DOI: 10.3389/fonc.2020.590083.
[16] Machado LF, Elias PCL, Moreira AC, et al. MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas[J]. Comput Biol Med, 2020, 124:103966. DOI: 10.1016/j.compbiomed.2020.103966.
[17] Shen C, Liu X, Jin J, et al. A novel magnetic resonance imaging-based radiomics and clinical predictive model for the regrowth of postoperative residual tumor in non-functioning pituitary neuroendocrine tumor[J]. Medicina (Kaunas), 2023, 59(9):1525. DOI: 10.3390/medicina59091525.
[18] 杨洪安,张景润,王家兴,等.基于MRI的放射组学评分和临床病理影像参数预测垂体瘤复发的Nomogram模型研究[J].放射学实践,2023,38(7):853-862.DOI:10.13609/j.cnki.1000-0313.2023.07.008.
[19] Lopes MBS. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary[J]. Acta Neuropathol, 2017, 134(4):521-535. DOI: 10.1007/s00401-017-1769-8.
[20] Zhang C, Heng X, Neng W, et al. Prediction of high infiltration levels in pituitary adenoma using MRI-based radiomics and machine learning[J]. Chin Neurosurg J, 2022, 8(1):21. DOI: 10.1186/s41016-022-00290-4.
[21] Ugga L, Cuocolo R, Solari D, et al. Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning[J]. Neuroradiology, 2019, 61(12):1365-1373. DOI: 10.1007/s00234-019-02266-1.
[22] Li H, Liu Z, Li F, et al. Preoperatively predicting Ki67 expression in pituitary adenomas using deep segmentation network and radiomics analysis based on multiparameter MRI[J]. Acad Radiol, 2024, 31(2):617-627. DOI: 10.1016/j.acra.2023.05.023.
[23] 赵继平.影像组学结合临床在预测无功能性垂体大腺瘤Ki-67高增殖指数及术后复发中的价值研究[D].沈阳:中国医科大学,2023.DOI:10.27652/d.cnki.gzyku.2023.001993.
[24] Mohyeldin A, Katznelson LJ, Hoffman AR, et al. Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes[J]. Sci Rep, 2022, 12(1):9919. DOI: 10.1038/s41598-022-12980-1.
[25] Niu J, Zhang S, Ma S, et al. Preoperative prediction of cavernous sinus invasion by pituitary adenomas using a radiomics method based on magnetic resonance images[J]. Eur Radiol, 2019, 29(3):1625-1634. DOI: 10.1007/s00330-018-5725-3.
[26] Cohen-Cohen S, Helal A, Yin Z, et al. Predicting pituitary adenoma consistency with preoperative magnetic resonance elastography[J]. J Neurosurg, 2021, 136(5):1356-1363. DOI: 10.3171/2021.6.JNS204425.
[27] Acitores Cancela A, Rodríguez Berrocal V, Pian Arias H, et al. Effect of pituitary adenoma consistency on surgical outcomes in patients undergoing endonasal endoscopic transsphenoidal surgery[J]. Endocrine, 2022, 78(3):559-569. DOI: 10.1007/s12020-022-03161-1.
[28] Zeynalova A, Kocak B, Durmaz ES, et al. Preoperative evaluation of tumour consistency in pituitary macroadenomas: a machine learning-based histogram analysis on conventional T2-weighted MRI[J]. Neuroradiology, 2019, 61(7):767-774. DOI: 10.1007/s00234-019-02211-2.
[29] Cuocolo R, Ugga L, Solari D, et al. Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI[J]. Neuroradiology, 2020, 62(12):1649-1656. DOI: 10.1007/s00234-020- 02502-z.
[30] Mendi BAR, Batur H, Çay N, et al. Radiomic analysis of preoperative magnetic resonance imaging for the prediction of pituitary adenoma consistency[J]. Acta Radiol, 2023, 64(8):2470-2478. DOI: 10.1177/02841851231174462.
[31] Wan T, Wu C, Meng M, et al. Radiomic features on multiparametric MRI for preoperative evaluation of pituitary macroadenomas consistency: preliminary findings[J]. J Magn Reson Imaging, 2022, 55(5):1491-1503. DOI: 10.1002/jmri.27930.
[32] Fan Y, Hua M, Mou A, et al. Preoperative noninvasive radiomics approach predicts tumor consistency in patients with acromegaly: development and multicenter prospective validation[J]. Front Endocrinol (Lausanne), 2019, 10:403. DOI: 10.3389/fendo.2019.00403.